Investing.com - Illumina reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Illumina announced earnings per share of $0.75 on revenue of $1.2B. Analysts polled by Investing.com anticipated EPS of $0.4562 on revenue of $1.13B.
Illumina shares are down 5.88% from the beginning of the year , still down 35.57% from its 52 week high of $555.77 set on Friday, February 12, 2021. They are outperforming the Nasdaq 100 which is down 9.89% year to date.
Illumina shares gained 0.76% in after-hours trade the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar